IBM Scientists Help Deliver Breast Cancer Breakthrough and 2 Other Dow Movers to Watch
International Business Machine Corp. (NYSE: IBM) Current price: $179.48
Scientists from IBM and Singapore’s Institute of Bioengineering and Nanotechnology on Friday published a breakthrough drug delivery technique that exhibited the first biodegradable, biocompatible and non-toxic hydrogel that is able to deliver treatment more efficiently to persons combating breast cancer. The scientists developed a novel synthetic hydrogel comprised of more than 96 percent water and a degradable polymer that can sequester a range of cargos from small molecules to large molecules including mAbs.
Goldman Sachs Group Inc. (NYSE:GS): Current price $162.06
Goldman Sachs Chairman for Brazil Paulo Leme believes that the country faces no imminent risk of losing its sovereign investment-grade debt ratings during the next 18 months. Presently, Brazil is rated Baa2 by Moody’s Investors Service and BBB by Standard and Poor’s and Fitch Ratings, which is the second-lowest investment-grade rating. However, Leme perceives a solid economy despite inflation and exchange rate volatility. The executive has not dismissed the possibility of a potential rating action but said that policies which improve predictability and transparency could lower the likelihood of a downgrade or further outlook revisions in the near-term.
Chevron Corp. (NYSE:CVX): Current price $118.16
An unexpected slide in Chevron Corp.’s quarterly profit can be attributed to refining weakness, while oil and gas well production rose but stayed below target. Capital spending is above budget, while output was under expectations because of a slow ramp-up of gas exports from Angola and harm to a customer’s gas facility in Thailand from a lightning strike, Chevron said Friday. However, a rebound in fourth-quarter oil and gas production would lead to the oil major pumping between 98 and 99 percent of its 2013 forecast of 2.65 million barrels of oil equivalent per day, according to a company spokesman to analysts on a conference call.
Don’t Miss: What Parts of Vodafone Does AT&T Want?